A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Clinical trial NCT07446491 · RECRUITING
Trial details
- NCT number
- NCT07446491
- Sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2026-05-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.